Table: Daito -Q1 group results

Daito Pharmaceutical

13/10/2021 07:00

Oct 13 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2021        Aug 31, 2020     May 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             11.75               13.70            42.50    
                                     (+17.5 pct)      (+6.2 pct)  
  Operating          2.36                1.95             5.90    
                 (+21.2 pct)         (+43.5 pct)      (-0.1 pct)  
  Recurring          2.42                1.97             6.00    
                 (+23.1 pct)         (+41.1 pct)      (-1.1 pct)  
  Net                1.83                1.32             4.25    
                 (+38.1 pct)         (+43.6 pct)      (+0.1 pct)  
  EPS            133.09 yen           98.08 yen       309.91 yen  
  Ann Div                             46.00 yen        50.00 yen  
  -Q2 div                             23.00 yen        25.00 yen  
  -Q4 div                             23.00 yen        25.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T